NAK Kazatomprom AO
NAK Kazatomprom AO
04/28/2022 | Press release | Distributed by Public on 04/28/2022 01:35
Biohaven Pharmaceutical Holding[...]
Biohaven Enrolls First Patient in Phase 3 Trial of Taldefgrobep alfa in[...]
iSpecimen Adds New Global Biospecimen Suppliers to Proprietary[...]
NAK Kazatomprom AO
04/28/2022 | Press release | Distributed by Public on 04/28/2022 01:35
Please select the service you want to use:
Smartlinks | NAK Kazatomprom AO | News | Disaster and Accident | Nuclear Accident | International News | Disaster and Accident | Nuclear Accident | Finance | Metals Markets | Stock Markets | Security Markets | Commodities | Stock Markets | Security Markets | Company News | Business Announcement | Nuclear Accident | Metals | Non-Ferrous Metals | Metals Markets | Mining | Public Companies | Uranium Exploration and Processing Companies | London Stock Exchange (LSE) | Börse Frankfurt | Börse Berlin | Börse Düsseldorf | Börse München | Börse Stuttgart | Turquoise | Cboe Off Exchange
Back
Copyright ©2006-2022 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact